Hostname: page-component-78c5997874-94fs2 Total loading time: 0 Render date: 2024-11-03T08:57:17.568Z Has data issue: false hasContentIssue false

OS3 - 187 Differentiating Radionecrosis from Tumor Progression Using IVIM perfusion Fraction in Brain Metastases Treated with Radiosurgery

Published online by Cambridge University Press:  18 October 2016

J Detsky*
Affiliation:
Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, ON
J Conklin
Affiliation:
University of Toronto, Toronto, ON
J Keith
Affiliation:
Sunnybrook Health Sciences Centre, Toronto, ON
S Symons
Affiliation:
Sunnybrook Health Sciences Centre, Toronto, ON
A Sahgal
Affiliation:
Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, ON
C Heyn
Affiliation:
Sunnybrook Health Sciences Centre, Toronto, ON
H Soliman
Affiliation:
Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, ON
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Radiation necrosis occurs in 5-25% of patients who undergo stereotactic radiosurgery (SRS) for brain metastases. Intravoxel incoherent motion (IVIM) uses MRI diffusion-weighted imaging (DWI) to assess regional perfusion. We investigated the utility of IVIM to differentiate recurrent tumor from radionecrosis after SRS. Patients who had SRS and subsequent surgical resection of what was thought to be either tumor progression or necrosis were included. ROIs were contoured on the pre-operative post-Gd T1-weighted images and transferred to DWI images using automated co-registration. The perfusion fraction (f) was calculated using asymptotic fitting and the mean f (fmean), 90th percentile for f (f90), mean ADC (ADCmean) and 10th percentile for ADC (ADC10) were calculated. Pathology reports were used to identify the predominant feature (necrosis versus tumor). Nine patients with ten lesions were included. One lesion exhibited pure necrosis while the other nine were mixed; three were predominantly (>75%) tumor, three predominantly necrosis, and three were equal parts of both. The perfusion fraction was significantly higher in cases with predominantly tumor compared to those with predominantly necrosis (fmean 0.10±0.01 vs 0.08±0.01, p=0.02 and f90 0.22±0.01 vs 0.14±0.02, p<0.001). ADC did not differentiate tumor from necrosis (ADCmean 0.97±0.23 vs 1.02±0.36, p=0.8 and ADC10 0.53±0.29 vs 0.76±0.29, p=0.33). The IVIM perfusion fraction is useful in differentiating recurrent tumor from radionecrosis in brain metastases treated with SRS. This is the first study to evaluate IVIM against the gold standard (histopathology).

Type
Oral Presentations
Copyright
Copyright © The Canadian Journal of Neurological Sciences Inc. 2016